medRxiv PreprintsInternational18 November 2026
Prospective multi-omic profiling identifies predictive and genetically supported molecular determinants of incident epilepsy
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Abstract Epilepsy affects approximately 50 million people worldwide, yet biomarkers capable of identifying individuals at risk before clinical onset are lacking, and the molecular mechanisms preceding disease onset remain poorly understood. Here, we integrated plasma proteomic, metabolomic, and genomic data from the UK Biobank to characterize molecular changes preceding epilepsy and evaluate their predictive and causal relevance. We quantified 2,923 plasma proteins in 53,000 participants and followed incident epilepsy for up to 15 years before epilepsy diagnosis. Cox proportional hazards analy
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Unmet needs of Polish patients with cystic fibrosis seen through the lens of crowdfunding20 November 2026
- Motherly Plus: Study Protocol of a Randomized Controlled Trial Evaluating a Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression20 November 2026
- Targeting memory consolidation in major depression via pharmacological slow-wave sleep promotion20 November 2026
- Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study20 November 2026
- Depressive Symptom Trajectories and Incident Cognitive Impairment by Outcome Ascertainment20 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.